Works by McHutchison, John G.

Results: 58
    1

    Development of sofosbuvir for the treatment of hepatitis C virus infection.

    Published in:
    Annals of the New York Academy of Sciences, 2015, v. 1358, n. 1, p. 56, doi. 10.1111/nyas.12832
    By:
    • Lawitz, Eric;
    • Jacobson, Ira M.;
    • Nelson, David R.;
    • Zeuzem, Stefan;
    • Sulkowski, Mark S.;
    • Esteban, Rafael;
    • Brainard, Diana;
    • McNally, John;
    • Symonds, William T.;
    • McHutchison, John G.;
    • Dieterich, Douglas;
    • Gane, Edward
    Publication type:
    Article
    2
    3

    Ledipasvir‐sofosbuvir for treating Japanese patients with chronic hepatitis C virus genotype 2 infection.

    Published in:
    Liver International, 2018, v. 38, n. 9, p. 1552, doi. 10.1111/liv.13685
    By:
    • Asahina, Yasuhiro;
    • Itoh, Yoshito;
    • Ueno, Yoshiyuki;
    • Matsuzaki, Yasushi;
    • Takikawa, Yasuhiro;
    • Yatsuhashi, Hiroshi;
    • Genda, Takuya;
    • Ikeda, Fusao;
    • Matsuda, Takuma;
    • Dvory‐Sobol, Hadas;
    • Jiang, Deyuan;
    • Massetto, Benedetta;
    • Osinusi, Anu O.;
    • Brainard, Diana M.;
    • McHutchison, John G.;
    • Kawada, Norifumi;
    • Enomoto, Nobuyuki
    Publication type:
    Article
    4

    Identification of hepatitis C virus 2k/1b intergenotypic recombinants in Georgia.

    Published in:
    Liver International, 2018, v. 38, n. 3, p. 451, doi. 10.1111/liv.13540
    By:
    • Zakalashvili, Mamuka;
    • Zarkua, Jaba;
    • Zangurashvili, Lela;
    • Kankia, Nino;
    • Jashiashvili, Nino;
    • Lomidze, Maka;
    • Telia, Tengiz;
    • Kerashvili, Vakhtang;
    • Zhamutashvili, Maia;
    • Abramishvili, Nikoloz;
    • Rtskhiladze, Irakli;
    • Metreveli, David;
    • Weizenegger, Michael;
    • Bartel, Jan;
    • Raabe, Monika;
    • Hedskog, Charlotte;
    • Chodavarapu, Krishna;
    • Brainard, Diana M.;
    • McHutchison, John G.;
    • Mo, Hongmei
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21

    An Exome Sequencing Study to Assess the Role of Rare Genetic Variation in Pulmonary Fibrosis.

    Published in:
    2017
    By:
    • Petrovski, Slavé;
    • Todd, Jamie L.;
    • Durheim, Michael T.;
    • Quanli Wang;
    • Chien, Jason W.;
    • Kelly, Fran L.;
    • Frankel, Courtney;
    • Mebane, Caroline M.;
    • Zhong Ren;
    • Bridgers, Joshua;
    • Urban, Thomas J.;
    • Malone, Colin D.;
    • Copeland, Ashley Finlen;
    • Brinkley, Christie;
    • Allen, Andrew S.;
    • O'Riordan, Thomas;
    • McHutchison, John G.;
    • Palmer, Scott M.;
    • Goldstein, David B.;
    • Wang, Quanli
    Publication type:
    journal article
    22

    Insulin resistance is independently associated with significant hepatic fibrosis in Asian chronic hepatitis C genotype 2 or 3 patients.

    Published in:
    Journal of Gastroenterology & Hepatology, 2011, v. 26, n. 7, p. 1182, doi. 10.1111/j.1440-1746.2011.06722.x
    By:
    • Patel, Keyur;
    • Thompson, Alexander J;
    • Chuang, Wan-Long;
    • Lee, Chuan-Mo;
    • Peng, Chen-Yuan;
    • Shanmuganathan, Ganesananthan;
    • Thongsawat, Satawat;
    • Tanwandee, Tawesak;
    • Mahachai, Varocha;
    • Pramoolsinsap, Chutima;
    • Cho, Mong;
    • Han, Kwang Hyup;
    • Shah, Samir R;
    • Foster, Graham R;
    • Clark, Paul J;
    • Pulkstenis, Erik;
    • Subramanian, G. Mani;
    • McHutchison, John G
    Publication type:
    Article
    23

    Sofosbuvir and Ribavirin for Hepatitis C in Patients With HIV Coinfection.

    Published in:
    JAMA: Journal of the American Medical Association, 2014, v. 312, n. 4, p. 353, doi. 10.1001/jama.2014.7734
    By:
    • Sulkowski, Mark S.;
    • Naggie, Susanna;
    • Lalezari, Jacob;
    • Fessel, Walford Jeffrey;
    • Mounzer, Karam;
    • Shuhart, Margaret;
    • Luetkemeyer, Anne F.;
    • Asmuth, David;
    • Gaggar, Anuj;
    • Liyun Ni;
    • Svarovskaia, Evguenia;
    • Brainard, Diana M.;
    • Symonds, William T.;
    • Subramanian, G. Mani;
    • McHutchison, John G.;
    • Rodriguez-Torres, Maribel;
    • Dieterich, Douglas
    Publication type:
    Article
    24
    25

    Sofosbuvir With Velpatasvir in Treatment-Naive Noncirrhotic Patients With Genotype 1 to 6 Hepatitis C Virus Infection: A Randomized Trial.

    Published in:
    2015
    By:
    • Everson, Gregory T.;
    • Towner, William J.;
    • Davis, Mitchell N.;
    • Wyles, David L.;
    • Nahass, Ronald G.;
    • Thuluvath, Paul J.;
    • Etzkorn, Kyle;
    • Hinestrosa, Federico;
    • Myron Tong;
    • Rabinovitz, Mordechai;
    • McNally, John;
    • Brainard, Diana M.;
    • Han, Lingling;
    • Doehle, Brian;
    • McHutchison, John G.;
    • Morgan, Timothy;
    • Chung, Raymond T.;
    • Tran, Tram T.;
    • Tong, Myron
    Publication type:
    journal article
    26

    Sofosbuvir Plus Velpatasvir Combination Therapy for Treatment-Experienced Patients With Genotype 1 or 3 Hepatitis C Virus Infection: A Randomized Trial.

    Published in:
    2015
    By:
    • Pianko, Stephen;
    • Flamm, Steven L.;
    • Shiftman, Mitchell L.;
    • Kumar, Sonal;
    • Strasser, Simone I.;
    • Dore, Gregory J.;
    • McNally, John;
    • Brainard, Diana M.;
    • Han, Lingling;
    • Doehle, Brian;
    • Mogalian, Erik;
    • McHutchison, John G.;
    • Rabinovitz, Mordechai;
    • Towner, William J.;
    • Gane, Edward J.;
    • Stedman, Catherine A. M.;
    • Reddy, K. Rajender;
    • Roberts, Stuart K.;
    • Shiffman, Mitchell L
    Publication type:
    journal article
    27
    28

    Re-treatment of Chronic Hepatitis C Virus Genotype 1 Infection After Relapse.

    Published in:
    Annals of Internal Medicine, 2014, v. 161, n. 9, p. 634, doi. 10.7326/M14-1211
    By:
    • Osinusi, Anu;
    • Kohli, Anita;
    • Marti, Miriam M.;
    • Nelson, Amy;
    • Xiaozhen Zhang;
    • Meissner, Eric G.;
    • Silk, Rachel;
    • Townsend, Kerry;
    • Pang, Phillip S.;
    • Subramanian, G. Mani;
    • McHutchison, John G.;
    • Fauci, Anthony S.;
    • Masur, Henry;
    • Kottilil, Shyam
    Publication type:
    Article
    29

    Ledipasvir/Sofosbuvir for 8 Weeks to Treat Acute Hepatitis C Virus Infections in Men With Human Immunodeficiency Virus Infections: Sofosbuvir-Containing Regimens Without Interferon for Treatment of Acute HCV in HIV-1 Infected Individuals.

    Published in:
    Clinical Infectious Diseases, 2019, v. 69, n. 3, p. 514, doi. 10.1093/cid/ciy913
    By:
    • Naggie, Susanna;
    • Fierer, Daniel S;
    • Hughes, Michael D;
    • Kim, Arthur Y;
    • Luetkemeyer, Annie;
    • Vu, Vincent;
    • Roa, Jhoanna;
    • Rwema, Steve;
    • Brainard, Diana M;
    • McHutchison, John G;
    • Peters, Marion G;
    • Kiser, Jennifer J;
    • Marks, Kristen M;
    • Chung, Raymond T;
    • Team, Acquired Immunodeficiency Syndrome Clinical Trials Group (ACTG) A5327 Study
    Publication type:
    Article
    30
    31

    Ledipasvir-Sofosbuvir Plus Ribavirin in Treatment-Naive Patients With Hepatitis C Virus Genotype 3 Infection: An Open-Label Study.

    Published in:
    Clinical Infectious Diseases, 2017, v. 65, n. 1, p. 13, doi. 10.1093/cid/cix289
    By:
    • Feld, Jordan J.;
    • Ramji, Alnoor;
    • Shafran, Stephen D.;
    • Willems, Bernard;
    • Marotta, Paul;
    • Huchet, Emmanuelle;
    • Vachon, Marie-Louise;
    • Svarovskaia, Evguenia S.;
    • Huang, K. C.;
    • Hyland, Robert H.;
    • Yun, Chohee;
    • Massetto, Benedetta;
    • Brainard, Diana M.;
    • McHutchison, John G.;
    • Tam, Edward;
    • Bailey, Robert;
    • Cooper, Curtis;
    • Yoshida, Eric M.;
    • Greenbloom, Susan;
    • Elkhashab, Magdy
    Publication type:
    Article
    32

    Sofosbuvir and Velpatasvir for the Treatment of Hepatitis C Virus in Patients Coinfected With Human Immunodeficiency Virus Type 1: An Open-Label, Phase 3 Study.

    Published in:
    Clinical Infectious Diseases, 2017, v. 65, n. 1, p. 6, doi. 10.1093/cid/cix260
    By:
    • Wyles, David;
    • Bräu, Norbert;
    • Kottili, Shyam;
    • Daar, Eric S.;
    • Ruane, Peter;
    • Workowski, Kimberly;
    • Luetkemeyer, Anne;
    • Adeyemi, Oluwatoyin;
    • Kim, Arthur Y.;
    • Doehle, Brian;
    • Huang, K. C.;
    • Mogalian, Erik;
    • Osinusi, Anu;
    • McNally, John;
    • Brainard, Diana M.;
    • McHutchison, John G.;
    • Naggie, Susanna;
    • Sulkowski, Mark
    Publication type:
    Article
    33
    34
    35

    Successful Retreatment of Chronic HCV Genotype-1 Infection With Ledipasvir and Sofosbuvir After Initial Short Course Therapy With Direct-Acting Antiviral Regimens.

    Published in:
    Clinical Infectious Diseases, 2016, v. 62, n. 3, p. 280, doi. 10.1093/cid/civ874
    By:
    • Wilson, Eleanor M.;
    • Kattakuzhy, Sarah;
    • Sidharthan, Sreetha;
    • Sims, Zayani;
    • Lydia Tang;
    • McLaughlin, Mary;
    • Price, Angie;
    • Nelson, Amy;
    • Silk, Rachel;
    • Gross, Chloe;
    • Akoth, Elizabeth;
    • Hongmei Mo;
    • Subramanian, G. Mani;
    • Pang, Phillip S.;
    • McHutchison, John G.;
    • Osinusi, Anu;
    • Masur, Henry;
    • Kohli, Anita;
    • Kottilil, Shyam
    Publication type:
    Article
    36

    Infrequent Development of Resistance in Genotype 1–6 Hepatitis C Virus–Infected Subjects Treated With Sofosbuvir in Phase 2 and 3 Clinical Trials.

    Published in:
    Clinical Infectious Diseases, 2014, v. 59, n. 12, p. 1666, doi. 10.1093/cid/ciu697
    By:
    • Svarovskaia, Evguenia S.;
    • Dvory‐Sobol, Hadas;
    • Parkin, Neil;
    • Hebner, Christy;
    • Gontcharova, Viktoria;
    • Martin, Ross;
    • Ouyang, Wen;
    • Han, Bin;
    • Xu, Simin;
    • Ku, Karin;
    • Chiu, Sophia;
    • Gane, Edward;
    • Jacobson, Ira M.;
    • Nelson, David R.;
    • Lawitz, Eric;
    • Wyles, David L.;
    • Bekele, Neby;
    • Brainard, Diana;
    • Symonds, William T.;
    • McHutchison, John G.
    Publication type:
    Article
    37

    Infections During Peginterferon/Ribavirin Therapy Are Associated With the Magnitude of Decline in Absolute Lymphocyte Count: Results of the IDEAL Study.

    Published in:
    Clinical Infectious Diseases, 2014, v. 58, n. 7, p. 960, doi. 10.1093/cid/ciu009
    By:
    • Melia, Michael T.;
    • Bräu, Norbert;
    • Poordad, Fred;
    • Lawitz, Eric J.;
    • Shiffman, Mitchell L.;
    • McHutchison, John G.;
    • Muir, Andrew J.;
    • Galler, Greg W.;
    • Nyberg, Lisa M.;
    • Lee, William M.;
    • Schiff, Eugene;
    • Long, Jianmin;
    • Noviello, Stephanie;
    • Brass, Clifford A.;
    • Pedicone, Lisa D.;
    • Sulkowski, Mark S.
    Publication type:
    Article
    38
    39
    40
    41

    Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir / Sofosbuvir Plus Ribavirin Pretransplant.

    Published in:
    Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2017, v. 16, n. 3, p. 375, doi. 10.5604/01.3001.0009.8592
    By:
    • Yoshida, Eric M.;
    • Kwo, Paul;
    • Agarwal, Kosh;
    • Duvoux, Christophe;
    • Durand, François;
    • Peck-Radosavljevic, Markus;
    • Lilly, Leslie;
    • Willems, Bernard;
    • Vargas, Hugo;
    • Kumar, Princy;
    • Brown Jr., Robert S.;
    • Horsmans, Yves;
    • De-Oertel, Shampa;
    • Arterburn, Sarah;
    • Dvory-Sobol, Hadas;
    • Brainard, Diana M.;
    • McHutchison, John G.;
    • Terrault, Norah;
    • Rizzetto, Mario;
    • Müllhaupt, Beat
    Publication type:
    Article
    42
    43
    44

    Interferon γ–Induced Protein10 Kinetics in Treatment-Naive Versus Treatment-Experienced Patients Receiving Interferon-Free Therapy for Hepatitis C Virus Infection: Implications for the Innate Immune Response.

    Published in:
    Journal of Infectious Diseases, 2014, v. 210, n. 12, p. 1881, doi. 10.1093/infdis/jiu325
    By:
    • Lin, Jennifer C.;
    • Habersetzer, François;
    • Rodriguez-Torres, Maribel;
    • Afdhal, Nezam;
    • Lawitz, Eric J.;
    • Paulson, Matthew S.;
    • Zhu, Yanni;
    • Subramanian, Gangadharan Mani;
    • McHutchison, John G.;
    • Sulkowski, Mark;
    • Wyles, David L.;
    • Schooley, Robert T.
    Publication type:
    Article
    45
    46
    47

    A Whole Recombinant Yeast-Based Therapeutic Vaccine Elicits HBV X, S and Core Specific T Cells in Mice and Activates Human T Cells Recognizing Epitopes Linked to Viral Clearance.

    Published in:
    PLoS ONE, 2014, v. 9, n. 7, p. 1, doi. 10.1371/journal.pone.0101904
    By:
    • King, Thomas H.;
    • Kemmler, Charles B.;
    • Guo, Zhimin;
    • Mann, Derrick;
    • Lu, Yingnian;
    • Coeshott, Claire;
    • Gehring, Adam J.;
    • Bertoletti, Antonio;
    • Ho, Zi Z.;
    • Delaney, William;
    • Gaggar, Anuj;
    • Subramanian, G. Mani;
    • McHutchison, John G.;
    • Shrivastava, Shikha;
    • Lee, Yu-Jin L.;
    • Kottilil, Shyamasundaran;
    • Bellgrau, Donald;
    • Rodell, Timothy;
    • Apelian, David
    Publication type:
    Article
    48
    49
    50